SCHEMBL21476083

SCHEMBL21476083

Cc1ccc(C(CC(=O)O)NC(=O)CCC(C)C)cc1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 2/20 0.53
NFE2L2 Q16236 2/20 0.53
CYP26A1 O43174 3/20 0.51
ITGB3 P05106 2/20 0.49
ITGA2B P08514 1/20 0.49
UTS2R Q9UKP6 2/20 0.49
POLB P06746 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
ITGAV P06756 1/20 0.47
ITGB5 P18084 1/20 0.47
ITGB6 P18564 1/20 0.47
ITGB8 P26012 1/20 0.47
KMT2A Q03164 1/20 0.45
CTSA P10619 4/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21476082 0.86 UTS2R (0.46) KEAP1NFE2L2UTS2RPOLBSMN1; SMN2
SCHEMBL6857598 0.83 KEAP1 (0.59) KEAP1NFE2L2CYP26A1ITGB3ITGA2B
SCHEMBL15654637 0.79 CYP26A1 (0.58) KEAP1NFE2L2CYP26A1POLBSMN1; SMN2
SCHEMBL7362926 0.77 KEAP1 (0.53) KEAP1NFE2L2CYP26A1ITGB3ITGA2B
SCHEMBL14408235 0.75 CYP26A1 (0.54) KEAP1NFE2L2CYP26A1POLBSMN1; SMN2
SCHEMBL15787346 0.75 CYP26A1 (0.54) KEAP1NFE2L2CYP26A1POLBSMN1; SMN2
SCHEMBL15787300 0.75 CYP26A1 (0.54) KEAP1NFE2L2CYP26A1POLBSMN1; SMN2
SCHEMBL21475910 0.73 P2RX7 (0.38) ITGB3ITGA2BITGAVITGB5ITGB6
SCHEMBL8453630 0.73 MME (0.51) KEAP1NFE2L2CYP26A1POLBALDH1A1
SCHEMBL9829245 0.73 SMN1; SMN2 (0.60) ITGB3ITGA2BPOLBSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019200202-A1 ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7) MORPHIC THERAPEUTIC, INC. (US) 2019-10-17 WO disclosed